Further, our recent studies have demonstrated that MUC4 results in oncogenic transformation of mouse fibroblasts [14], contributes to the drug-resistance of pancreatic cancer cells by activating anti-apoptotic pathways [15], and is involved in the epithelial-to-mesenchymal transition in ovarian cancer cells [16]. Here, MUC4 is linked to ovarian carcinoma.